Frequency and spectrum of Wolcott-Rallison syndrome in Saudi Arabia: A systematic review

Libyan Journal of Medicine

Volumn 8, Issue 1, 2013, Pages

  Habeb, Abdelhadi M ^a  

^a King Salman Bin Abdulaziz Medical City   (Saudi Arabia)

Author keywords

EIF2AK3 mutations; Neonatal diabetes; Saudi Arabia; Wolcott Rallison syndrome

Indexed keywords

BONE DYSPLASIA; CHILD; EIF2 AK3 GENE; FREQUENCY ANALYSIS; GENE; GENE MUTATION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; GEOGRAPHIC DISTRIBUTION; HEPATITIS; HUMAN; MEDLINE; MORTALITY; NEWBORN DIABETES MELLITUS; PERMANENT NEONATAL DIABETES MELLITUS; REVIEW; SAUDI ARABIA; SYSTEMATIC REVIEW; WOLCOTT RALLISON SYNDROME; CHONDRODYSPLASIA; CONGENITAL MALFORMATION; EIF2AK3 MUTATIONS; EPIPHYSIS; FEMALE; GENETICS; GENOTYPE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MUTATION; NEONATAL DIABETES; NEWBORN; ONSET AGE; PHENOTYPE; PRESCHOOL CHILD; PROGNOSIS; WOLCOTT-RALLISON SYNDROME;

EIF2AK3 PROTEIN, HUMAN; PROTEIN KINASE R;

EIF2AK3 MUTATIONS; NEONATAL DIABETES; SAUDI ARABIA; WOLCOTT-RALLISON SYNDROME;

AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; EIF-2 KINASE; EPIPHYSES; FEMALE; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION; OSTEOCHONDRODYSPLASIAS; PHENOTYPE; PROGNOSIS; SAUDI ARABIA;

EID: 84879153654     PISSN: 19932820     EISSN: 18196357     Source Type: Journal    
DOI: 10.3402/ljm.v8i0.21137     Document Type: Review

References (48)

1. Wolcott CD, Rallison MV. Infancy-onset diabetes mellitus and multiple epiphyseal dysplasia. J Pediatr. 1972; 80: 292-297.
2. Julier C, Nicolino M. Wolcott-Rallison syndrome. Orphanet J Rare Dis. 2010; 5: 29.
3. Senee V, Vattem KM, Delepine M, Rainbow LA, Haton C, Lecoq A, et al. Wolcott-Rallison syndrome: clinical, genetic, and functional study of EIF2AK3 mutations and suggestion of genetic heterogeneity. Diabetes. 2004; 53: 1876-1883.
4. Rubio-Cabezas O, Patch AM, Minton JA, Flanagan SE, Edghill EL, Hussain K, et al. Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families. J Clin Endocrinol Metab. 2009; 94: 4162-4170.
5. Delepine M, Nicolino M, Barrett T, Golamaully M, Lathrop GM, Julier C. EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott-Rallison syndrome. Nat Genet. 2000; 25: 406-409.
6. Harding HP, Zeng H, Zhang Y, Jungries R, Chung P, Plesken H, et al. Diabetes mellitus and exocrine pancreatic dysfunction in perk -/- mice reveals a role for translational control in secretory cell survival. Mol Cell. 2001; 7: 1153-1163.
7. Zhang P, McGrath B, Li S, Frank A, Zambito F, Reinert J, et al. The PERK eukaryotic initiation factor 2 alpha kinase is required for the development of the skeletal system, postnatal growth, and the function and viability of the pancreas. Mol Cell Biol. 2002; 22: 3864-3874.
8. Feng D, Wei J, Gupta S, McGrath BC, Cavener DR. Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation. BMC Cell Biol. 2009; 10: 61.
9. Gupta S, McGrath B, Cavener DR. PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway. Diabetes. 2010; 59: 1937-1947.
10. Iida K, Li Y, McGrath BC, Frank A, Cavener DR. PERK eIF2 alpha kinase is required to regulate the viability of the exocrine pancreas in mice. BMC Cell Biol. 2007; 8: 38.
11. Wei J, Sheng X, Feng D, McGrath B, Cavener DR. PERK is essential for neonatal skeletal development to regulate osteoblast proliferation and differentiation. J Cell Physiol. 2008; 217: 693.
12. Habeb AM, Flanagan S, Deeb A, Al-Alwan I, Alawneh H, Balafrej AA, et al. Permanent neonatal diabetes: different aetiology in Arabs compared with Europeans. Arch Dis Child. 2012; 97: 721-723.
13. El-Mouzan MI, Al-Salloum AA, Al-Herbish AS, Qurachi MM, Al-Omar AA. Regional variations in the prevalence of consanguinity in Saudi Arabia. Saudi Med J. 2007; 28(12): 1881-1884.
14. Habeb AM, Al-Magamsi MSF, Eid I, Ali MI, Hattersley AT, Hussain K, et al. Incidence, genetics and clinical phenotype of permanent neonatal diabetes in northwest Saudi Arabia. Pediatr Diabetes. 2012; 13(6): 499-505.
15. Bonthron DT, Dunlop N, Barr DG, El Sanousi AA, Al-Gazali LI. Organisation of the human PAX4 gene and its exclusion as a candidate for the Wolcott-Rallison syndrome. J Med Genet. 1998; 35: 288-292.
16. Brickwood S, Bonthron DT, Al-Gazali LI, Piper K, Hearn T, Wilson DI, et al. Wolcott-Rallison syndrome: pathogenic insights into neonatal diabetes from new mutation and expression studies of EIF2AK3. J Med Genet. 2003; 40: 685-689.
17. AL-Shawi M, Al-Mutair A, Ellard S, Habeb AM. Variable phenotype in 5 patients with WRS due to the same mutation. J Pediatr Endocrinol Metab. 2012 Jun 20: 1-4. doi: 10.1515/ jpem-2012-0071. [Epub ahead of print].
18. Al-Gazali LI, Makia S, Azzam A, Hall CM. Wolcott-Rallison syndrome. Clin Dysmorphol. 1995; 4: 227-233.
19. Abdelrahman S, Bin-Abbas B, Al-Ashwal A. Wolcott-Rallison syndrome in a Saudi infant. Curr Pediatr Res. 2000; 1: 51-52.
20. Bin-Abbas B, Shabib S, Hainau B, Al-Ashwal A. Wolcott-Rallison syndrome: clinical, radiological and histological findings in a Saudi child. Ann Saudi Med. 2001; 21: 73-74.
21. Bin-Abbas B, Al-Mulhim A, Al-Ashwal A. Wolcott-Rallison syndrome in two siblings with isolated central hypothyroidism. Am J Med Genet. 2002; 111: 187-190.
22. Marafie MJ, Redha MA, Al-Naggar RL. Wolcott-Rallison syndrome in a Bedouin boy. Ann Saudi Med. 2004; 24: 476-479.
23. Mihci E, Türkkahraman D, Ellard S, Akcurin S, Bircan I. Wolcott-Rallison syndrome due to a novel mutation (R491X) in EIF2AK3 gene. J Clin Res Pediatr Endocrinol. 2012; 4(2): 101-103. doi: 10.4274/jcrpe.619.
24. Reis AF, Kannengiesser C, Jennane F, Manna TD, Cheurfa N, Oudin C, et al. Two novel mutations in the EIF2AK3 gene in children with Wolcott-Rallison syndrome. Pediatr Diabetes. 2011; 12(3 Pt1): 187-191.
25. Feng DR, Meng Y, Zhao SM, Shi HP, Wang WC, Huang SZ. Two novel EIF2AK3 mutations in a Chinese boy with Wolcott-Rallison syndrome. Zhonghua Er Ke Za Zhi. 2011; 49(4): 301-305.
26. Sang Y, Liu M, Yang W, Yan J, Chengzhu, Ni G A novel EIF2AK3 mutation leading to Wolcott-Rallison syndrome in a Chinese child. J Pediatr Endocrinol Metab. 2011; 24(3-4): 181-184.
27. Ozbek MN, Senee V, Aydemir S. Wolcott-Rallison syndrome due to the same mutation (W522X) in EIF2AK3 in two unrelated families and review of the literature. Pediatr Diabetes. 2010; 11: 279-285.
28. Goumy O, Maroteux P, Stanescu V, Stanescu R, Labbe A, Menut G Syndrome de transmission recessive autosomeique anociant un diabete congenital et desdesordes de la croissance des epiphyses. Arch Franc Pediatr. 1980; 37: 323-328.
29. Stoss H, Pesch HJ, Pontz B, Otten A, Spranger J. Wolcott-Rallison syndrome: diabetes mellitus and spondyloepiphyseal dysplasia. Eur J Pediatr. 1982; 138: 120-129.
30. Biason-Lauber A, Lang-Muritano M, Vaccaro T, Schoenle EJ. Loss of kinase activity in a patient with Wolcott-Rallison syndrome caused by a novel mutation in the EIF2AK3 gene. Diabetes. 2002; 51: 2301-2305.
31. Castelnau P, Le Merrer M, Diatloff-Zito C, Marquis E, Tete MJ, Robert JJ. Wolcott-Rallison syndrome: a case with endocrine and exocrine pancreatic deficiency and pancreatic hypotrophy. Eur J Pediatr. 2000; 159: 631-633.
32. de Wit MC, de Coo IF, Julier C. Microcephaly and simplified gyral pattern of the brain associated with early onset insulin-dependent diabetes mellitus. Neurogenetics. 2006; 7: 259-263.
33. Durocher F, Faure R, Labrie Y, Pelletier L, Bouchard I, Laframboise R. A novel mutation in the EIF2AK3 gene with variable expressivity in two patients with Wolcott-Rallison syndrome. Clin Genet. 2006; 70: 34-38.
34. Iyer S, Korada M, Rainbow L, Kirk J, Brown RM, Shaw N, et al. Wolcott-Rallison syndrome: a clinical and genetic study of three children, novel mutation in EIF2AK3 and a review of the literature. Acta Paediatr. 2004; 93:1195-1201.
35. Thornton CM, Carson DJ, Stewart FJ. Autopsy findings in the Wolcott-Rallison syndrome. Pediatr Pathol Lab Med. 1997; 17(3): 487-496.
36. Stewart FJ, Carson DJ, Thomas PS, Humphreys M, Thornton C, Nevin NC. Wolcott-Rallison syndrome associated with congenital malformations and a mosaic deletion 15q 11-12. Clin Genet. 1996; 49(3): 152-155.
37. Sovik O, Njolstad PR, Jellum E, Molven A. Wolcott-Rallison syndrome with 3-hydroxydicarboxylic aciduria and lethal outcome. J Inherit Metab Dis. 2008; 31(Suppl 2): S293-297.
38. Engelmann G, Meyburg J, Shahbek N, Al-Ali M, Hairetis MH, Baker AJ, et al. Recurrent acute liver failure and mitochondrio-pathy in a case of Wolcott-Rallison syndrome. J Inherit Metab Dis. 2008; 31(4): 540-546.
39. Stanik J, Gasperikova D, Paskova M, Barak L, Javorkova J, Jancova E, et al. Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers. J Clin Endocrinol Metab. 2007; 92: 1276-1282.
40. Grulich-Henn J, Wagner V, Thon A, Schober E, Marg W, Kapellen TM, et al. Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV). Diabet Med. 2010; 27: 709-717.
41. Taha D, Bardise J, Hegab A, Bonnefond A, Marchand M, Drunat S, et al. Neonatal diabetes mellitus because of pancreatic agenesis with dysmorphic features and recurrent bacterial infections. Pediatr Diabetes. 2008; 9: 240-244.
42. Taha D, Barbar M, Kanaan H, Williamson Balfe J. Neonatal diabetes mellitus, congenital hypothyroidism, hepatic fibrosis, polycystic kidneys, and congenital glaucoma: a new autosomal recessive syndrome? Am J Med Genet A. 2003; 122A(3): 269-273.
43. Senee V, Chelala C, Duchatelet S, Feng D, Blanc H, Cossec JC, et al. Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism. Nat Genet. 2006; 38(6): 682-687.
44. Attia N, Zahrani A, Saif R, Kattan HA, Sakati N, Al Ashwal A, et al. Different faces of non-autoimmune diabetes of infancy. Acta Paediatr. 1998; 87(1): 95-7.
45. Mathew PM, Hann RW, Hamdan JA. Neonatal diabetes mellitus in first cousins. Clin Pediatr (Phila). 1988; 27(5): 247-251.
46. Al-Mahdi M, Al Mutair A, Al Balwi M, Hussain K. Successful transfer from insulin to oral sulfonylurea in a 3-year-old girl with a mutation in the KCNJ11 gene. Ann Saudi Med. 2010; 30(2): 162-164.
47. Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010; 140: 900-917.
48. Cunha DA, Ladriere L, Ortis F, Igoillo-Esteve M, Gurzov EN, Lupi R, et al. Glucagon-like peptide-1 agonists protect pancreatic -cells from lipotoxic endoplasmic reticulum stress through upregulation of BiP and JunB. Diabetes. 2009; 58: 2851-2862.